Acute Endothelial Allograft Rejection After Inoculation With the Novel Messenger RNA SARS-CoV-2 Vaccines
Eye Banking and Corneal Transplantation · 2022
DOI: 10.1097/ebct.0000000000000004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eye Banking and Corneal Transplantation, 2022. Verfasst von Dorian A. Zeidenweber und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The aim of this study was to report 3 cases of corneal endothelial allograft rejection shortly after immunization with SARS-CoV-2 messenger RNA (mRNA) vaccines and to describe the clinical course, management, and outcomes.
Methods
This is a retrospective case series.
Results
Three patients presented with corneal endothelial rejection 3 weeks after the second dose of a SARS-CoV-2 mRNA vaccine: a 25-year-old woman's 8-month status post-Descemet stripping endothelial keratoplasty for a failed penetrating keratoplasty (PK) (Pfizer-BioNTech COVID-19 vaccine), a 70-year-old man's 4-year status post-PK (Pfizer-BioNTech COVID-19 vaccine), and a 45-year-old woman's 8-month status post-PK (Moderna COVID-19 vaccine). Each of the patients was on a maintenance dose of prednisolone acetate twice daily, which was increased to 4 times daily before the first dose of Pfizer-BioNTech COVID-19 vaccine in the 25-year-old woman. At the time of diagnosis of endothelial rejection, prednisolone acetate was increased to every 1–2 hours for each patient, with resolution of the rejection in the PK recipients but progression to endothelial failure in the Descemet stripping endothelial keratoplasty recipient.
Conclusions
Our report provides further evidence of a potential association between mRNA vaccines and corneal allograft rejection. Contrary to prior reports, corneal endothelial rejection associated with COVID-19 vaccines may be sufficiently severe to result in irreversible graft failure despite steroid prophylaxis.
Zitieren
APA
Zeidenweber, D. A., Aldave, A. J., & Fung, S. S. M. (2022). Acute Endothelial Allograft Rejection After Inoculation With the Novel Messenger RNA SARS-CoV-2 Vaccines. Eye Banking and Corneal Transplantation. https://doi.org/10.1097/ebct.0000000000000004
Vancouver
Zeidenweber DA, Aldave AJ, Fung SSM. Acute Endothelial Allograft Rejection After Inoculation With the Novel Messenger RNA SARS-CoV-2 Vaccines. Eye Banking and Corneal Transplantation. 2022. doi:10.1097/ebct.0000000000000004
BibTeX
@article{Zeidenweber2022,
author = {Zeidenweber, Dorian A. and Aldave, Anthony J. and Fung, Simon S. M.},
title = {Acute Endothelial Allograft Rejection After Inoculation With the Novel Messenger RNA SARS-CoV-2 Vaccines},
journal = {Eye Banking and Corneal Transplantation},
year = {2022},
doi = {10.1097/ebct.0000000000000004}
}
EUVIMED